CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Velcera Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Velcera Inc
SUITE 170, 777 TOWNSHIP LINE ROAD
Phone: (267) 757-3600p:267 757-3600 YARDLEY, PA  19067-5508  United States Ticker: VLCR VLCR
This company was Merged or Acquired on 4/1/2013.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Velcera, Inc. is a United States-based pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the pet health market. The Company offers Promist delivery system, a technology for the administration of pet medicines. It delivers a metered-dose liquid mist to the inside of the mouth, providing for easy, quick systemic absorption. Promist is a patented oral mucosa drug delivery system. Oral mucosa delivery system, is a precise metered dose of the medication can be sprayed as a fine mist on the inside surface of the animals cheek and gums.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/200812/31/2007-Yes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
6770 Blank checks

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board John M.Preston 61 5/1/2004
Chief Executive Officer, Director Dennis F.Steadman 55 5/1/2004 5/1/2004
Chief Financial Officer Matthew M.Hill 39 5/1/2007 5/1/2007
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Denali Sciences, Inc.
Fidopharm, Inc.
Velcera Inc.
Velcera, Inc.
VLCR

General Information
Number of Employees: 7 (As of 12/31/2007)
Outstanding Shares: 12,059,579 (As of 8/12/2008)
Shareholders: 275
Stock Exchange: OTC
Federal Tax Id: 203327015
Fax Number: (302) 636-5454


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023